Duopharma Biotech Bhd (XKLS:7148) Scaled Net Operating Assets

: 0.79 (As of Sep. 2023)

View and export this data going back to 2002. Start your Free Trial

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Duopharma Biotech Bhd's operating assets for the quarter that ended in Sep. 2023 was RM1,101.6 Mil. Duopharma Biotech Bhd's operating liabilities for the quarter that ended in Sep. 2023 was RM119.2 Mil. Duopharma Biotech Bhd's Total Assets for the quarter that ended in Jun. 2023 was RM1,248.8 Mil. Therefore, Duopharma Biotech Bhd's scaled net operating assets (SNOA) for the quarter that ended in Sep. 2023 was 0.79.

Duopharma Biotech Bhd Scaled Net Operating Assets Historical Data

The historical data trend for Duopharma Biotech Bhd's Scaled Net Operating Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Duopharma Biotech Bhd Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Scaled Net Operating Assets

0.89

0.81

0.86

0.84

0.80

Duopharma Biotech Bhd Quarterly Data
	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23
Scaled Net Operating Assets																0.77	0.76	0.80	0.78	0.79

Competitive Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Duopharma Biotech Bhd's Scaled Net Operating Assets, along with its competitors' market caps and Scaled Net Operating Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Duopharma Biotech Bhd Scaled Net Operating Assets Distribution

For the Drug Manufacturers industry and Healthcare sector, Duopharma Biotech Bhd's Scaled Net Operating Assets distribution charts can be found below:

* The bar in red indicates where Duopharma Biotech Bhd's Scaled Net Operating Assets falls into.

Duopharma Biotech Bhd Scaled Net Operating Assets Calculation

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Duopharma Biotech Bhd's Scaled Net Operating Assets (SNOA) for the fiscal year that ended in Dec. 2022 is calculated as

	Scaled Net Operating Assets (SNOA)		(A: Dec. 2022 )
=	(Operating Assets (A: Dec. 2022 )	-	Operating Liabilities (A: Dec. 2022 ))	/	Total Assets (A: Dec. 2021 )
=	(1064.282	-	135.094)	/	1164.131
=	0.80

where

	Operating Assets		(A: Dec. 2022 )
=	Total Assets	-	Cash, Cash Equivalents, Marketable Securities
=	1221.919	-	157.637
=	1064.282

	Operating Liabilities		(A: Dec. 2022 )
=	Total Liabilities	-	Long-Term Debt & Capital Lease Obligation	-	Short-Term Debt & Capital Lease Obligation
=	566.697	-	296.522	-	135.081
=	135.094

Duopharma Biotech Bhd's Scaled Net Operating Assets (SNOA) for the quarter that ended in Sep. 2023 is calculated as

	Scaled Net Operating Assets (SNOA)		(Q: Sep. 2023 )
=	(Operating Assets (Q: Sep. 2023 )	-	Operating Liabilities (Q: Sep. 2023 ))	/	Total Assets (Q: Jun. 2023 )
=	(1101.618	-	119.151)	/	1248.792
=	0.79

where

	Operating Assets		(Q: Sep. 2023 )
=	Total Assets	-	Cash, Cash Equivalents, Marketable Securities
=	1383.502	-	281.884
=	1101.618

	Operating Liabilities		(Q: Sep. 2023 )
=	Total Liabilities	-	Long-Term Debt & Capital Lease Obligation	-	Short-Term Debt & Capital Lease Obligation
=	708.982	-	362.677	-	227.154
=	119.151

Duopharma Biotech Bhd Scaled Net Operating Assets Related Terms

Thank you for viewing the detailed overview of Duopharma Biotech Bhd's Scaled Net Operating Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Duopharma Biotech Bhd (XKLS:7148) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Duopharma Biotech Bhd (XKLS:7148) » Definitions » Scaled Net Operating Assets

Comparable Companies

Traded in Other Exchanges

N/A

Address

Lot 2599, Jalan Seruling 59, Kawasan 3, Taman Klang Jaya, Klang, MYS, 41200

Website

https://www.duopharmabiotech.com

Duopharma Biotech Bhd is an investment holding company engaged in manufacturing pharmaceuticals. It develops, manufactures, and markets generic and over-the-counter pharmaceutical products. The operating segment of the company is the manufacturing and distribution of pharmaceutical products. The principal activities of its subsidiary are to carry out business as a manufacturer, distributor, importer and exporter of pharmaceutical products and medicines.

Duopharma Biotech Bhd (XKLS:7148) Headlines

No Headlines